Cargando…
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
Ganglioside GM1 is a member of the ganglioside family which has been used in many countries and is thought of as a promising alternative treatment for preventing several neurological diseases, including cerebral ischemic injury. The therapeutic effects of GM1 have been proved both in neonates and in...
Autores principales: | Zhang, Wenchao, Krafft, Paul R., Wang, Tianlong, Zhang, John H., Li, Li, Tang, Jiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686431/ https://www.ncbi.nlm.nih.gov/pubmed/30666888 http://dx.doi.org/10.1177/0963689718822782 |
Ejemplares similares
-
Protection against Experimental Stroke by Ganglioside GM1 Is Associated with the Inhibition of Autophagy
por: Li, Li, et al.
Publicado: (2016) -
Ganglioside GM1 and the Central Nervous System
por: Guo, Zhongwu
Publicado: (2023) -
Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
por: Allende, Maria L., et al.
Publicado: (2023) -
GM1 ganglioside-independent intoxication by Cholera toxin
por: Cervin, Jakob, et al.
Publicado: (2018) -
Turning the spotlight on the oligosaccharide chain of GM1 ganglioside
por: Chiricozzi, Elena, et al.
Publicado: (2021)